abagovomab 32
abciximab 30
abituzumab 22
abrilumab 19
actoxumab 18
adalimumab 20
aducanumab 13
afasevikumab 20
alacizumab_pegol 13
alemtuzumab 23
alirocumab 21
amatuximab 40
andecaliximab 23
anifrolumab 22
anrukinzumab 22
aprutumab 18
aprutumab_ixadotin 18
arcitumomab 25
ascrinvacumab 7
atezolizumab 16
atinumab 16
avelumab 14
basiliximab 30
bavituximab 37
begelomab 27
benralizumab 26
bevacizumab_beta 24
bezlotoxumab 18
bimagrumab 13
bleselumab 15
blinatumomab 34
blosozumab 29
bococizumab 17
brazikumab 15
brentuximab_vedotin 31
briakinumab 18
brodalumab 12
brolucizumab 27
brontictuzumab 25
burosumab 17
cabiralizumab 25
camrelizumab 14
canakinumab 24
cantuzumab_ravtansin 46
carlumab 15
carotuximab 30
cergutuzumab_amunaleukin2 24
cergutuzumab_amunaleukin 24
certolizumab_pegol 25
cetiximab 46
citatuzumab_bogatox 27
cixutumumab 26
clivatuzumab_tetraxetan 22
codrituzumab 31
conatumumab 13
concizumab 33
crenezumab 21
crizanlizumab 25
crotedumab 21
dacetuzumab 22
daclizumab 10
dalotuzumab 39
dapirolizumab_pegol 25
daratumumab 14
dectrekumab 11
demcizumab 23
denosumab 10
depatuxizumab 22
depatuxizumab_mafodotin 22
dezamizumab 18
dinutuximab 36
diridavumab 26
domagrozumab 17
drozitumab 16
duligotuzumab 21
durvalumab 11
dusigitumab 17
efalizumab 32
efungumab 29
eldelumab 15
elezanumab 20
elgemtumab 11
elotuzumab 18
emactuzumab 19
emapalumab 25
emibetuzumab 16
enavatuzumab 25
enfortumab_vedotin 14
enoblituzumab 20
enokizumab 23
enoticumab 18
ensituximab 33
eptinezumab 19
erenumab 22
etaracizumab 18
etrolizumab 22
evinacumab 22
evolocumab 15
farletuzumab 14
fasinumab 21
fezakinumab 20
fibatuzumab 12
ficlatuzumab 20
firivumab 34
flanvotumab 18
fletikumab 22
foralumab 13
foravirumab 14
fremanezumab 30
fresolimumab 17
fulranumab 22
futuximab 30
galcanezumab 18
ganitumab 26
gantenerumab 11
gemetuzumab 28
gemtuzumab2 25
gemtuzumab 23
gevokizumab 24
girentuximab 31
glembatumumab 17
glembatumumab_vedotin 17
guselkumab 24
ibalizumab 24
ibritumomab 31
icrucumab 10
idarucizumab 36
ifabotuzumab 12
imalumab 18
imgatuzumab 19
inclacumab 20
indatuximab_ravtansin 33
indusatumab 15
inebilizumab 29
intetumumab 15
iodine_girentuximab 30
ipilimumab 3
iratumumab 13
isatuximab 37
itolizumab 27
ixekizumab 32
labetuzumab_govitecan 21
lambrolizumab 27
lampalizumab 24
lanadelumab 18
landogrozumab 18
laprituximab 24
lebrikizumab 35
lendalizumab 23
lenzilumab 15
lifastuzumab_vedotin 25
ligelizumab 23
lilotomab 36
lirilumab 22
lodelcizumab 16
lokivetmab 25
lorvotuzumab_mertansin 28
lucatumumab 28
lumretuzumab 17
lupartumab 16
lutikizumab 21
margetuximab 34
milatuzumab 42
mirvetuximab 34
mirvetuximab_soravtansin 34
modotuximab 41
mogamulizumab 36
monalizumab 16
motavizumab 34
moxetumomab_pasudotox 33
namilumab 16
naratuximab 29
naratuximab_emtansin 29
narnatumab 19
navicixizumab2 28
navicixizumab 24
navivumab 36
necitumumab 12
nemolizumab 24
nesvacumab 17
nivolumab 12
obiltoxaximab 21
obinutuzumab 36
ocaratuzumab 26
ofatumumab 19
olaratumab 19
olokizumab 25
omalizumab 20
onartuzumab 22
ontuxizumab 22
opicinumab 14
orticumab 16
otelixizumab 39
oxelumab 12
ozanezumab 31
pamrevlumab 11
panobacumab 30
parsatuzumab 25
pasotuxizumab 23
pateclizumab 16
patritumab 19
pembrolizumab 27
perakizumab 23
pidilizumab 19
pinatuzumab_vedotin 19
plozalizumab 33
pogalizumab 22
polatuzumab_vedotin 22
ponezumab 37
prezalumab 15
pritoxaximab 30
quilizumab 23
racotumomab 28
radretumab 15
ralpancizumab 20
ramucirumab 14
ranevetmab 27
ranibizumab 24
refanezumab 25
remtolumab 19
rilotumumab 19
rinucumab 18
risankizumab 34
rituximab 20
rivabazumab 20
robatumumab 20
roledumab 32
romosozumab 20
rontalizumab 19
rosmantuzumab 21
rozanolixizumab 22
sacituzumab 29
sacituzumab_govitecan 29
samalizumab 23
sapelizumab 23
sarilumab 18
secukinumab 15
seribantumab 17
setoxaximab 43
sifalimumab 9
siltuximab 25
simtuzumab 27
sirukumab 13
solanezumab 27
solitomab 24
stamulumab 16
suptavumab 25
suvizumab 21
tabalumab 11
tadocizumab 18
tamtuvetmab 31
tanezumab 22
tarextumab 11
tavolixizumab 18
telisotuzumab 26
teplizumab 21
tesidolumab 22
tezepelumab 24
tigatuzumab 17
tildrakizumab 19
timolumab 15
tisotumab 15
tosatoxumab 39
tositumomab 31
tralokinumab 23
trastuzumab 23
tregalizumab 25
trevogrumab 13
ublituximab 29
urelumab 20
ustekinumab 28
utomilumab 27
vadastuximab 23
vadastuximab_talirin 23
vandortuzumab_vedotin 15
vantictumab 22
vanucizumab2 24
vanucizumab 26
varlilumab 14
vatelizumab 21
vedolizumab 27
veltuzumab 15
vesencumab 12
vorsetuzumab 23
vorsetuzumab_mafodotin 23
vunakizumab 34
xentuzumab 20
zatuximab 41
